Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158

Authors not listed

H. Lundbeck A/S · 2004

Abstract

The primary objective of the study was to examine the safety and tolerability of memantine in outpatients with moderate to severe Alzheimer's Disease.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-11 MST

Cite this

APA
Anonymous. (2004). An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158. <em>H. Lundbeck A/S</em>. https://clinicaltrials.gov/study/NCT00857233
Vancouver
Anonymous. An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158. H. Lundbeck A/S. 2004.
BibTeX
@misc{anon2004AnOpen, title = {An Open-label Extension Study Examining the Safety and Tolerability of Memantine in Patients With Moderate to Severe Dementia of the Alzheimer's Type Having Completed Study 10158}, author = {Anonymous}, journal = {H. Lundbeck A/S}, year = {2004}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings